About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
MGI:1314884
135 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Birc2tm1.1Rbr/Birc2tm1.1Rbr
Birc3tm1.1Rbr/Birc3tm1.1Rbr
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
involves: BALB/cJ * C57BL/6 * SJL 		postnatal lethality, complete penetrance J:182515
Chuktm1Ver/Chuktm1Ver
Ikbkbtm1Ver/Ikbkbtm1Ver
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129/Sv * 129S4/SvJae * C57BL/6J 		broad limb buds J:63443
curly tail J:63443
lethality throughout fetal growth and development, complete penetrance J:63443
open neural tube J:63443
Chuktm1Ver/Chuktm1Ver
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129/Sv * 129S4/SvJae * C57BL/6J 		broad limb buds J:63443
curly tail J:63443
Chuktm1Yhu/Chuktm1Yhu
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tg(KRT5-cre)5132Jlj/0
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 		epidermal hyperplasia J:141162
postnatal lethality J:141162
thick epidermis J:141162
Faslpr/Faslpr
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
involves: 129/Sv * C57BL/6 		liver inflammation J:92470
Fastm1Cgn/Fastm1Cgn
Mogtm1(cre)Gkl/Mog+
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * C57BL/6 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
normal immune system phenotype J:114741
Fastm1Cgn/Fastm1Cgn
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * C57BL/6 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
Ifngtm1Ts/Ifngtm1Ts
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 		abnormal lymph node cortex morphology J:119206
abnormal lymph node primary follicle morphology J:119206
abnormal lymph node secondary follicle morphology J:119206
absent lymph node germinal center J:119206
absent spleen germinal center J:119206
increased eosinophil cell number J:119206
increased leukocyte cell number J:119206
increased lymphocyte cell number J:119206
increased susceptibility to fungal infection J:119206
lung inflammation J:119206
small Peyer's patches J:119206
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tg(KRT14-cre)1Cgn/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 		normal integument phenotype J:208995
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tg(KRT14-cre)1Cgn/0
involves: 129S2/SvPas * C57BL/6 * DBA/2 		normal integument phenotype J:208995
Ikbkbtm1Cgn/Ikbkbtm1Cgn
Tnfrsf1atm2Gkl/Tnfrsf1atm2Gkl
Tg(KRT14-cre)1Cgn/0
involves: 129S/SvEv * C57BL/6 * DBA/2 		epidermal hyperplasia J:208995
skin inflammation J:208995
skin lesions J:208995
Ikbkbtm1Ver/Ikbkbtm1Ver
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6J 		postnatal lethality J:54323
Ikbkgtm1.1Dwat/Ikbkgtm1.1Dwat
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac 		premature death J:202106
Ikbkgtm1.1Dwat/Y
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac 		abnormal hepatocyte morphology J:202106
abnormal liver physiology J:202106
abnormal liver regeneration J:202106
hepatic steatosis J:202106
normal immune system phenotype J:202106
increased circulating alanine transaminase level J:202106
increased circulating aspartate transaminase level J:202106
increased circulating bilirubin level J:202106
increased circulating lactate dehydrogenase level J:202106
liver fibrosis J:202106
liver inflammation J:202106
macrovesicular hepatic steatosis J:202106
microvesicular hepatic steatosis J:202106
premature death J:202106
preweaning lethality, incomplete penetrance J:202106
Il1r1tm1Imx/Il1r1tm1Imx
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
involves: 129S7/SvEvBrd * C57BL/6 		abnormal chemokine level J:126652
decreased interleukin-6 secretion J:115094
decreased susceptibility to experimental autoimmune uveoretinitis J:115094
dental pulp necrosis J:58851
impaired neutrophil recruitment J:126652
increased bone resorption J:58851
increased susceptibility to bacterial infection J:58851
interstitial pneumonia J:126652
lung inflammation J:126652
osteomyelitis J:58851
Lepob/Lepob
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
involves: 129S7/SvEvBrd * C57BL/6 		abnormal adipose tissue morphology J:55722
abnormal metabolism J:55722
decreased circulating insulin level J:55722
Map3k7tm1Aki/Map3k7tm1Aki
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tg(Tek-cre)12Flv/0
involves: 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6 		normal cardiovascular system phenotype J:191285
normal cellular phenotype J:191285
dilated vasculature J:191285
embryonic lethality during organogenesis, complete penetrance J:191285
Otulintm1c(EUCOMM)Hmgu/Otulintm1c(EUCOMM)Hmgu
Tg(KRT14-cre)1Cgn/0
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * C57BL/6 * C57BL/6N * DBA/2 		normal immune system phenotype J:312394
normal integument phenotype J:312394
Rag1tm1Bal/Rag1tm1Bal
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
involves: 129/Sv * C57BL/6 		liver inflammation J:92470
Relatm1.1Gho/Relatm1.1Gho
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 		abnormal eye development J:134684
blindness J:134684
premature death J:134684
prenatal lethality, incomplete penetrance J:134684
Relatm1.2Gho/Relatm1.2Gho
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 		premature death J:134684
Relatm1Bal/Relatm1Bal
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
involves: 129S4/SvJae * C57BL/6 		abnormal spleen germinal center morphology J:60742
abnormal thymus morphology J:60742
decreased body size J:60742
decreased spleen white pulp amount J:60742
extramedullary hematopoiesis J:60742
focal hepatic necrosis J:60742
heart inflammation J:60742
liver inflammation J:60742
lung inflammation J:60742
postnatal lethality, complete penetrance J:60742
Relatm2.1Gho/Relatm2.1Gho
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * 129S6/SvEvTac 		abnormal cornea epithelium morphology J:163663
cornea vascularization J:163663
decreased cornea thickness J:163663
increased cornea epithelium thickness J:163663
increased incidence of corneal inflammation J:163663
liver fibrosis J:163663
liver inflammation J:163663
premature death J:163663
Ripk3tm2Vmd/Ripk3tm2Vmd
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
involves: C57BL/6 * C57BL/6N 		embryonic lethality prior to tooth bud stage J:209137
Tab2tm2.1Aki/Tab2tm2.1Aki
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tg(Tek-cre)12Flv/0
involves: 129P2/OlaHsd * C3H * C57BL/6 		abnormal vascular development J:191285
embryonic lethality during organogenesis, complete penetrance J:191285
Tbk1tm1Yeh/Tbk1tm1Yeh
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129P2/OlaHsd * C57BL/6J 		normal mortality/aging J:91653
Tg(CAG-Lyn*)#Paau/0
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * C57BL/6 * DBA/2 		normal integument phenotype J:151886
Tg(Gfap-TNF*)K21Gkl/0
Tnfrsf1atm1Blt/Tnfrsf1a+
involves: 129P2/OlaHsd * C57BL/6 * CBA 		abnormal nervous system physiology J:106592
demyelination J:106592
Tg(INS-Il10)#Sar/0
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * C57BL/6J * NOD 		increased circulating glucose level J:64051
increased susceptibility to autoimmune diabetes J:64051
Tg(KRT5-Nfkbia*)3Rto/0
Tg(Krt5-Tnfr1)#Rsab/0
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * C57BL/6 * CBA 		epidermal hyperplasia J:208995
postnatal lethality, incomplete penetrance J:208995
skin inflammation J:208995
Tg(TNF)197Gkl/0
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
involves: 129 * C57BL/6 * CBA 		autoimmune arthritis J:92470
TnfBpsm1/Tnf+
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * C57BL/6 		increased circulating tumor necrosis factor level J:226052
normal skeleton phenotype J:226052
TnfBpsm1/TnfBpsm1
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
involves: 129S2/SvPas * C57BL/6 		increased circulating tumor necrosis factor level J:226052
normal skeleton phenotype J:226052
Tnfem5Boui/Tnf+
Tnfrsf1atm1Mak/Tnfrsf1a+
involves: 129S2/SvPas * C57BL/6 		abnormal lung morphology J:306876
autoimmune arthritis J:306876
cardiovalvulitis J:306876
colitis J:306876
premature death J:306876
preweaning lethality, incomplete penetrance J:306876
Tnftm1Gkl/Tnftm1Gkl
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
involves: 129S/SvEv * C57BL/6 		normal immune system phenotype J:92470
Tnftm2Gkl/Tnf+
Tnfrsf1atm2Gkl/Tnfrsf1atm2Gkl
Tg(Col6a1-cre)1Gkl/0
involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA 		normal cardiovascular system phenotype J:264147
Tnftm2Gkl/Tnf+
Tnfrsf1atm2Gkl/Tnfrsf1atm2Gkl
Tg(Col6a1-cre)1Gkl/?
involves: 129S/SvEv * C57BL/6 * CBA 		autoimmune arthritis J:131930
small intestinal inflammation J:131930
Tnftm2Gkl/Tnftm2Gkl
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 		increased circulating tumor necrosis factor level J:54056
increased tumor necrosis factor secretion J:54056
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tg(Vil1-cre)997Gum/0
involves: 129S2/SvPas * C57BL/6 * SJL 		decreased susceptibility to induced colitis J:163410
increased susceptibility to induced colitis J:163410
Tnfaip3tm1Ama/Tnfaip3tm1Ama
Tnfrsf1atm1Imx/Tnfrsf1a+
involves: C57BL/6J 		abnormal inflammatory response J:92694
cachexia J:92694
decreased body size J:92694
premature death J:92694
Tnfaip3tm1Ama/Tnfaip3tm1Ama
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
involves: C57BL/6J 		abnormal inflammatory response J:92694
cachexia J:92694
decreased body size J:92694
premature death J:92694
Tnfaip8l1em1Huwa/Tnfaip8l1em1Huwa
Tnfrsf1aem2Smoc/Tnfrsf1aem2Smoc
Tnfrsf1bem1Smoc/Tnfrsf1bem1Smoc
C57BL/6-Tnfrsf1bem1Smoc Tnfrsf1aem2Smoc Tnfaip8l1em1Huwa 		normal digestive/alimentary phenotype J:342074
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
involves: 129/Sv * C57BL/6 		liver inflammation J:92470
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 		abnormal lymph node cortex morphology J:119206
abnormal lymph node primary follicle morphology J:119206
abnormal lymph node secondary follicle morphology J:119206
absent lymph node germinal center J:119206
absent spleen germinal center J:119206
decreased IgG1 level J:115225
decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
normal immune system phenotype J:119206
increased susceptibility to parasitic infection J:114203
small Peyer's patches J:119206
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Il1r1tm1Imx/Il1r1tm1Imx
B6;129S-Tnfrsf1atm1Imx Il1r1tm1Imx/J 		abnormal brain wave pattern J:137505
abnormal circadian temperature homeostasis J:137505
abnormal sleep pattern J:137505
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tg(Ins2-Cxcl13)1Cys/0
involves: C57BL/6 * DBA/2 		abnormal lymph organ development J:110548
abnormal pancreatic islet morphology J:110548
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tg(Thy1-APP)3Somm/0
involves: C57BL/6 * C57BL/6J * DBA/2 		amyloid beta deposits J:134832
normal behavior/neurological phenotype J:134832
cerebral amyloid angiopathy J:134832
microgliosis J:134832
normal nervous system phenotype J:134832
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
B6.129S-Tnfrsf1btm1Imx Tnfrsf1atm1Imx/J 		decreased susceptibility to Coronaviridae infection J:288523
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
involves: 129S7/SvEvBrd * C57BL/6 		abnormal body temperature homeostasis J:48865
abnormal bone healing J:70467
abnormal glial cell physiology J:78637
abnormal kidney morphology J:69294
abnormal nervous system morphology J:78637
abnormal neuron physiology J:33864
abnormal retina blood vessel morphology J:104652
abnormal thrombosis J:117987
abnormal trabecular bone morphology J:70467
decreased food intake J:48865
decreased inflammatory response J:45147
decreased microglial cell activation J:33864
decreased physiological sensitivity to xenobiotic J:51349
decreased susceptibility to dopaminergic neuron neurotoxicity J:78637
decreased susceptibility to endotoxin shock J:45147
decreased susceptibility to experimental autoimmune uveoretinitis J:115094
decreased susceptibility to induced arthritis J:120707
decreased susceptibility to induced morbidity/mortality J:48865
dental pulp necrosis J:58851
impaired skeletal muscle regeneration J:104990
increased bone resorption J:58851
increased cerebral infarct size J:33864
increased circulating tumor necrosis factor level J:45147
increased myocardial infarct size J:62223
increased susceptibility to bacterial infection J:58851
increased susceptibility to neuronal excitotoxicity J:33864
normal nervous system phenotype J:33864
osteomyelitis J:58851
pulmonary fibrosis J:51349
renal interstitial fibrosis J:69294
seizures J:112713
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Vasntm1Zgl/Vasntm1Zgl
involves: C57BL/6 		normal reproductive system phenotype J:173568
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 		anemia J:180054
decreased body weight J:180054
decreased hemoglobin content J:180054
glomerulonephritis J:180054
increased neutrophil cell number J:180054
increased susceptibility to systemic lupus erythematosus J:180054
premature death J:180054
prenatal lethality, incomplete penetrance J:180054
spleen hyperplasia J:180054
Xbp1tm2Glm/Xbp1tm2Glm
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tg(Vil1-cre)997Gum/0
involves: 129S6/SvEvTac * C57BL/6 * SJL 		small intestinal inflammation J:206084
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory